Sotera Health Company (SHC) — Financial statements
Income statement, balance sheet, and cash flow for Sotera Health Company — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,164↑5.7% | 1,100↑4.9% | 1,049↑4.5% | 1,004↑7.8% | 931 | |
| Cost of Revenue | 518↑4.0% | 498↑5.5% | 472↑5.7% | 447↑8.2% | 413 | |
| Gross Profit | 646↑7.2% | 602↑4.4% | 577↑3.6% | 557↑7.4% | 519 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 253↑4.2% | 243↑2.5% | 237↓3.7% | 246↑24.0% | 198 | |
| Other Expenses | 0.00↓100.0% | 62↓2.8% | 64↑1.4% | 63↓1.3% | 64 | |
| Operating Expenses | 253↓17.0% | 305↑1.4% | 300↓2.7% | 309↑17.8% | 262 | |
| Total Costs & Expenses | 771↓4.0% | 803↑3.9% | 773↑2.3% | 755↑11.9% | 675 | |
| Operating Results | ||||||
| Operating Income | 393↑32.0% | 298↑7.6% | 277↑11.4% | 248↓3.3% | 257 | |
| Depreciation & Amortization | 0.00↓100.0% | 164↑3.6% | 158↑8.5% | 146↓3.5% | 151 | |
| EBITDA | 303↓31.4% | 442↑8.7% | 407↑2436.4% | -17↓104.3% | 401 | |
| EBIT | 303↑8.9% | 279↑11.9% | 249↑252.7% | -163↓165.2% | 250 | |
| Interest & Other Income | ||||||
| Net Interest Income | -156↑5.4% | -165↓15.3% | -143↓78.3% | -80↓8.0% | -74 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 156↓5.4% | 165↑15.3% | 143↑78.3% | 80↑8.0% | 74 | |
| Non-Operating Income | 90↑369.8% | 19↓31.4% | 28↓93.2% | 411↑5926.6% | 7 | |
| Other Income / Expenses | -245↓33.5% | -184↓7.7% | -171↑65.3% | -491↓506.6% | -81 | |
| Income Before Tax | 148↑29.5% | 114↑7.4% | 106↑143.6% | -243↓238.4% | 176 | |
| Income Tax Expense | 70↑0.1% | 69↑27.1% | 55↑672.8% | -10↓116.3% | 59 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 78↑75.6% | 44↓13.6% | 51↑122.0% | -234↓299.4% | 117 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 78↑75.6% | 44↓13.6% | 51↑122.0% | -234↓299.8% | 117 | |
| Bottom-Line Net Income | 78↑75.6% | 44↓13.6% | 51↑122.0% | -234↓302.5% | 115 | |
| EPS (Basic) | 0.27↑68.8% | 0.16↓11.1% | 0.18↑121.7% | -0.83↓302.4% | 0.41 | |
| EPS (Diluted) | 0.27↑68.8% | 0.16↓11.1% | 0.18↑121.7% | -0.83↓302.4% | 0.41 | |
| Weighted Average Shares | 284↑0.4% | 283↑0.6% | 281↑0.3% | 280↑0.3% | 279 | |
| Weighted Average Diluted Shares | 286↑0.5% | 285↑0.6% | 283↑1.1% | 280↑0.3% | 279 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.